4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
3.41
-0.19 (-5.28%)
At close: May 23, 2025, 10:59 AM
4D Molecular Therapeutics Revenue
4D Molecular Therapeutics reported an annual revenue of $37K, reflecting a -99.82% growth. For the quarter ending March 31, 2025, 4D Molecular Therapeutics generated $0 in revenue.
Revenue (ttm)
$37K
Revenue Growth
-99.82%
Price / Sales Ratio
8120.72
Revenue / Employee
$163
Employees
227
Market Cap
157.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|